Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK – Trademark Portfolio
Entity Type: 03
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RHOPHYLAC. The owner is based in CH-3000 Berne 22.
10, Wankdorfstrasse
CH-3000 Berne 22 , CH
Showing of trademarks Trademarks
Trademark Classifications
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK have?
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 abandoned, 2 cancelled.
What trademark classes does Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK file in?
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK's most well-known trademarks?
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK's registered trademark portfolio includes well-known marks such as RHOPHYLAC. These are among 1 currently registered trademark in the portfolio.
What is Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK's trademark registration success rate?
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.